Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) announced its earnings results on Tuesday. Cyclerion Therapeutics had a negative net margin of 170.11% and a negative return on equity of 62.10%. Cyclerion Therapeutics Stock Up 0.9%CYCN stock traded up $0.03 during midday trading on Tuesday, reaching $3.52. Get Cyclerion Therapeutics alerts:Analyst Ratings ChangesSeparately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cyclerion Therapeutics in a report on Friday, July 24th. Institutional Trading of Cyclerion TherapeuticsA hedge fund recently bought a new stake in Cyclerion Therapeutics stock.